Nippon India Pharma Fund vs HDFC Pharma and Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High Risk | Very High Risk |
Asset Size (Cr) | ₹1568 Cr | ₹8161 Cr |
Min Investment | ₹100 | ₹5000 |
Min SIP Invesment | ₹100 | ₹500 |
Min Addl Investment | ₹100 | ₹1000 |
Launch Date | 04 Oct 2023 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare Index | BSE Healthcare |
Turn Over | % | 21% |
Expense Ratio | 2.14 | 1.82 |
Manager | Dhruv Muchhal | Sailesh Raj Bhan |
ISIN Code | INF179KC1HL7 | INF204K01968 |
Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | -5.74% | -6% |
6 Month | -1.25% | -8.47% |
1 Year | 21.28% | 6.77% |
3 Year | - | 18.71% |
5 Year | - | 22.93% |
SIP Return Analysis
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | - | - |
1 Year | 13.16% | -2.3% |
3 Year | - | 21.23% |
5 Year | - | 19.2% |
Rolling Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 51.48% | 18.19% |
3 Year | - | 20.5% |
5 Year | - | 20.36% |
Risk Management
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | - | 15.185% |
Sharp | - | 0.81% |
Beta | - | 0.931% |
Alpha | - | -0.33% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Dhruv Muchhal | Sailesh Raj Bhan |
Total AUM | ₹520687 Cr | ₹96086 Cr |
Fund Manage | 40 | 5 |
HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 1.98 | 4.4 |
Small Cap | 33.12 | 22.52 |
Large Cap | 32.5 | 45.96 |
Mid Cap | 32.4 | 27.12 |
Sector Allocation
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 1.98 | 4.4 |
Pharmaceuticals & Biotechnology | 74.71 | 75.86 |
Healthcare Services | 22.28 | 17.38 |
Retailing | 1.03 | 2.36 |
Top Comparisons
ITI Balanced Advantage Fund Regular - Growth
3Y Returns7.95%
Mahindra Manulife Balanced Advantage Fund - Regular Plan - Growth
3Y Returns10.71%
Mahindra Manulife Equity Savings Fund - Regular Plan - Growth
3Y Returns7.95%
HDFC Equity Savings Fund - GROWTH PLAN
3Y Returns9.23%
WhiteOak Capital Multi Cap Fund - Regular (G)
3Y Returns0%
Edelweiss Multi Cap Fund - Regular (G)
3Y Returns0%
HDFC Banking and PSU Debt Fund - Growth Option
3Y Returns6.15%
INVESCO INDIA BANKING AND PSU FUND - Growth Option
3Y Returns5.37%